CN110205299A - 一种新型鸡cef重编程为pgc的诱导体系的建立方法 - Google Patents
一种新型鸡cef重编程为pgc的诱导体系的建立方法 Download PDFInfo
- Publication number
- CN110205299A CN110205299A CN201910514421.9A CN201910514421A CN110205299A CN 110205299 A CN110205299 A CN 110205299A CN 201910514421 A CN201910514421 A CN 201910514421A CN 110205299 A CN110205299 A CN 110205299A
- Authority
- CN
- China
- Prior art keywords
- culture solution
- culture
- cef
- cell
- pgc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 20
- 230000006698 induction Effects 0.000 title claims abstract description 19
- 230000008672 reprogramming Effects 0.000 title claims abstract description 14
- 241000700605 Viruses Species 0.000 claims abstract description 10
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 claims abstract description 7
- 238000000926 separation method Methods 0.000 claims abstract description 5
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims abstract description 4
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims abstract description 4
- 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 claims abstract description 4
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims abstract description 4
- 102100025460 Protein lin-28 homolog A Human genes 0.000 claims abstract description 4
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims abstract description 4
- 230000008676 import Effects 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 56
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 239000006285 cell suspension Substances 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 6
- 210000001161 mammalian embryo Anatomy 0.000 claims description 6
- 229920000209 Hexadimethrine bromide Polymers 0.000 claims description 5
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 5
- 108010076089 accutase Proteins 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000006481 glucose medium Substances 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 229960004857 mitomycin Drugs 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 229930192392 Mitomycin Natural products 0.000 claims description 3
- 108010019160 Pancreatin Proteins 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 230000009668 clonal growth Effects 0.000 claims description 3
- 238000013377 clone selection method Methods 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 3
- 238000011017 operating method Methods 0.000 claims description 3
- 229940055695 pancreatin Drugs 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000001890 transfection Methods 0.000 claims description 3
- 210000001835 viscera Anatomy 0.000 claims description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 3
- 241000894007 species Species 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 39
- 241000271566 Aves Species 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/605—Nanog
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/608—Lin28
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种新型鸡CEF重编程为PGC的诱导体系的建立方法,属于生物技术领域。在分离的原代CEF中,慢病毒外源导入OCT4,SOX2,NANOG,LIN28重编程因子,连续培养21天后,利用SSEA‑1抗体进行iPSC细胞株鉴定,鉴定为阳性的细胞株进行更换为BMP4/BMP8b/EGF诱导体系,诱导成为iPGC。本发明解决了濒危品种鸡PGC获取的数量低的问题,实现了濒危鸡品种的种质资源保护和物种复原工作。
Description
技术领域
本发明涉及一种新型鸡CEF重编程为PGC的诱导体系的建立方法,属于生物技术领域。
背景技术
在哺乳动物家畜中,体细胞核移植、体外受精和胚胎移植技术均已成功,能够结合精子、卵子、胚胎甚至是体细胞的冻存,实现种质资源的保护和物种复原。但是由于卵生的特点,上述方法均难以在家禽上实现。
家禽的原始生殖细胞(Primordial germ cell, PGC)具有独特的通过血液迁移定居于性腺的特点,使得PGC迁移路径成为实现禽类物种复原的唯一途径。但是单个胚胎所获取的PGC远不足以满足实际应用所需。尤其是濒危品种的PGC来源成为了限制这一技术的难题。而禽类的成纤维细胞(CEF)能够在短期内大量获取,若能将其诱导成PGC无疑是解决禽类物种复原的最佳路径。
发明内容
本发明旨在克服禽类体细胞诱导形成生殖细胞的障碍难题,提供一种重复性好又高效的鸡CEF重编程为PGC的诱导体系,即一种新型鸡CEF重编程为PGC的诱导体系的建立方法。
本发明的技术方案如下:
一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,在分离好的原代CEF中,慢病毒外源导入OCT4, SOX2, NANOG, LIN28重编程因子,连续培养21天后,利用SSEA-1抗体进行iPSC细胞株鉴定,鉴定为阳性的细胞进行更换为BMP4/BMP8b/EGF诱导体系,诱导成为iPGC。
优选地,具体操作方法如下:
步骤1:取出10日龄的鸡胚,放入加有1%青链霉素的PBS中,去除四肢,头及内脏,剩余组织使用胰酶消化5min,吹匀,400目滤筛过滤后制备CEF细胞悬液,以1200rpm/min离心六分钟,弃上清以培养液A成悬,1×105个细胞/孔接种于24孔板中,培养24小时;
步骤2:四种慢病毒以1:1:1:1的比例混合,以感染复数MOI=10与 400μl培养液B混合,加入24孔板中培养6小时后弃去含病毒的培养液B,换入新的培养液B,18小时后换培养液A,48小时观察转染效果;
步骤3:观察结束后将培养液A更换为培养液C,培养48小时后可以观察到细胞形态由梭状逐渐变化成圆形并出现聚团和克隆生长现象;
步骤4:继续培养48小时后,可以观察到克隆逐渐明显,进行单细胞克隆挑取;在体式显微镜下通过口吸管挑取iPS样克隆集落,加入含有20μlaccutase的96孔板中消化10分钟,再将细胞悬液重新接种于铺有饲养层细胞的96孔板中,加入100μl的培养液C进行培养;
步骤5:继续培养14天直至典型iPSC细胞出现,期间每3-5天根据细胞状态更换饲养层细胞;
步骤6:将SSEA-1红色荧光直标抗体用PBS稀释100倍,每孔加入5μl稀释后抗体混匀,2小时后在倒置荧光显微镜下观察细胞是否能标记上红色荧光,筛选iPSC细胞系;
步骤7:将能标记上红色荧光的细胞由96孔板传代至铺有2×105个细胞/孔的24孔板中传代培养;
步骤8:弃去24孔板中的上清,加入200μl Accutase消化带有饲养层细胞的iPSC 10分钟;加入400μl培养液C终止消化,差速贴壁40分钟取上清以1×105个细胞/孔接种于以16.7μg/ml人胎盘膜黏连蛋白包被1小时的24孔板中,以培养液D进行培养;
步骤9:培养4天后通过Cvh抗体标记后,流式细胞分选收集阳性细胞记为iPGC。
优选地,所述步骤5中,更换饲养层细胞操作方法:按照步骤1中的方法分离CEF,以1×106个细胞/60mm皿接种以培养液A培养24小时;以含有10μg/ml丝裂霉素C的培养液A处理2.5小时后更换为普通的培养液A继续培养24小时,以5×104个细胞/孔接种96孔板。
优选地,所述培养液A由45mlDMEM高糖培养基、5%FBS、1%青链霉素构成。
优选地,所述培养液B由培养液A、5μg/ml polybrene构成。
优选地,所述培养液C由43.5ml KO-DMEM培养基、5%FBS、1%鸡血清、1%青链霉素、0.4%非必须氨基酸、0.2μlβ-巯基乙醇、100μl hSCF (5ng/ml)、100μlbfgf(10ng/ml)、50μlLIF(10ng/ml)构成。
优选地,所述培养液D由培养液C、500ng/mlBMP4、500 ng/ml BMP8b、50 ng/ml EGF构成。
本发明的有益效果如下:
本发明解决了濒危品种鸡PGC获取的数量低的问题,实现了濒危鸡品种的种质资源保护和物种复原工作。
附图说明
图1为本发明中CEF在第五天发生形态变化,出现聚团生长的细胞克隆示意图。
具体实施方式
本发明中所需原材料(括号为厂商):
金开瑞公司构建的OCT4, SOX2, NANOG, LIN28过表达载体,并慢病毒包装好,滴度为1×108UI/mL;孵化至10日龄的鸡胚。
DMEM高糖培养基(Hyclone),FBS(Gibco), 青链霉素(碧云天),Polybrene(碧云天),KO-DMEM(Gibco),鸡血清(Gibco),非必须氨基酸(sigma),β-巯基乙醇(sigma),hSCF(sigma),bfgf(sigma),Lif(sigma),BMP4(Prospec), BMP8b(R&D Systems),EGF (R&DSystems),accutase(Gibco),SSEA-1(R&D Systems),Cvh(abcam),丝裂霉素C(sigma)。
本发明中所需培养基配方为:
培养液A:DMEM高糖培养基,(体积浓度百分比)5%FBS, (体积浓度百分比)1%青链霉素。
培养液B: 培养液A,5μg/ml polybrene(聚凝胺)。
培养液C:43.5ml KO-DMEM培养基,(体积浓度百分比)5%FBS,(体积浓度百分比)1%鸡血清,(体积浓度百分比)1%青链霉素,(体积浓度百分比)0.4%非必须氨基酸,0.2μlβ-巯基乙醇,100μl hSCF (5ng/ml),100μlbfgf(10ng/ml),50μl LIF(10ng/ml)。
培养液D:培养液C,500ng/mlBMP4,500 ng/ml BMP8b, 50 ng/ml EGF。
本发明具体步骤为:
步骤1:取出10日龄的鸡胚,放入加有1%青链霉素的PBS中,去除四肢,头及内脏,剩余组织使用胰酶消化5min,吹匀,400目滤筛过滤后制备CEF细胞悬液,以1200rpm/min离心六分钟,弃上清以培养液A成悬,1×105个细胞/孔接种于24孔板中,培养24小时。
步骤2:四种慢病毒以1:1:1:1的比例混合,以感染复数MOI=10与 400μl培养液B混合,加入24孔板中培养6小时后弃去含病毒的培养液B,换入新的培养液B,18小时后换培养液A,48小时观察转染效果。
步骤3:观察结束后将培养液A更换为培养液C,培养48小时后可以观察到细胞形态由梭状逐渐变化成圆形并出现聚团和克隆生长现象(如图1所示)。
步骤4:继续培养48小时后,可以观察到克隆逐渐明显,进行单细胞克隆挑取。在体式显微镜下通过口吸管挑取iPS样克隆集落,加入含有20μlaccutase的96孔板中消化10分钟,再将细胞悬液重新接种于铺有饲养层细胞的96孔板中,加入100μl的培养液C进行培养。
步骤5:继续培养14天直至典型iPSC细胞出现,期间每3-5天根据细胞状态更换饲养层细胞。更换饲养层细胞操作方法:按照步骤1中的方法分离CEF,以1×106个细胞/60mm皿接种以培养液A培养24小时。以含有10μg/ml丝裂霉素C的培养液A处理2.5小时后更换为普通的培养液A继续培养24小时,以5×104个细胞/孔接种96孔板。
步骤6:将SSEA-1红色荧光直标抗体用PBS稀释100倍,每孔加入5μl稀释后抗体混匀,2小时后在倒置荧光显微镜下观察细胞是否能标记上红色荧光,筛选iPSC细胞系。
步骤7:将能标记上红色荧光的细胞由96孔板传代至铺有2×105个细胞/孔的24孔板中传代培养。
步骤8:弃去24孔板中的上清,加入200μl Accutase消化带有饲养层细胞的iPSC10分钟。加入400μl培养液C终止消化,差速贴壁40分钟取上清以1×105个细胞/孔接种于以16.7μg/ml人胎盘膜黏连蛋白包被的24孔板中,以培养液D进行培养。
步骤9:培养4天后通过Cvh抗体标记后,流式细胞分选收集阳性细胞记为iPGC。
Claims (7)
1.一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,在分离的原代CEF中,慢病毒外源导入OCT4, SOX2, NANOG, LIN28重编程因子,连续培养21天后,利用SSEA-1抗体进行iPSC细胞株鉴定,鉴定为阳性的细胞株进行更换为BMP4/BMP8b/EGF诱导体系,诱导成为iPGC。
2.根据权利要求1所述的一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,具体操作方法如下:
步骤1:取出10日龄的鸡胚,放入加有1%青链霉素的PBS中,去除四肢,头及内脏,剩余组织使用胰酶消化5min,吹匀,400目滤筛过滤后制备CEF细胞悬液,以1200rpm/min离心六分钟,弃上清以培养液A成悬,1×105个细胞/孔接种于24孔板中,培养24小时;
步骤2:四种慢病毒以1:1:1:1的比例混合,以感染复数MOI=10与 400μl培养液B混合,加入24孔板中培养6小时后弃去含病毒的培养液B,换入新的培养液B,18小时后换培养液A,48小时观察转染效果;
步骤3:观察结束后将培养液A更换为培养液C,培养48小时后可以观察到细胞形态由梭状逐渐变化成圆形并出现聚团和克隆生长现象;
步骤4:继续培养48小时后,可以观察到克隆逐渐明显,进行单细胞克隆挑取;在体式显微镜下通过口吸管挑取iPS样克隆集落,加入含有20μlaccutase的96孔板中消化10分钟,再将细胞悬液重新接种于铺有饲养层细胞的96孔板中,加入100μl的培养液C进行培养;
步骤5:继续培养14天直至典型iPSC细胞出现,期间每3-5天根据细胞状态更换饲养层细胞;
步骤6:将SSEA-1红色荧光直标抗体用PBS稀释100倍,每孔加入5μl稀释后抗体混匀,2小时后在倒置荧光显微镜下观察细胞是否能标记上红色荧光,筛选iPSC细胞系;
步骤7:将能标记上红色荧光的细胞由96孔板传代至铺有2×105个细胞/孔的24孔板中传代培养;
步骤8:弃去24孔板中的上清,加入200μl Accutase消化带有饲养层细胞的iPSC 10分钟;加入400μl培养液C终止消化,差速贴壁40分钟取上清以1×105个细胞/孔接种于以16.7μg/ml人胎盘膜黏连蛋白包被1小时的24孔板中,以培养液D进行培养;
步骤9:培养4天后通过Cvh抗体标记后,流式细胞分选收集阳性细胞记为iPGC。
3.根据权利要求2所述的一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,所述步骤5中,更换饲养层细胞操作方法:按照步骤1中的方法分离CEF,以1×106个细胞/60mm皿接种以培养液A培养24小时;以含有10μg/ml丝裂霉素C的培养液A处理2.5小时后更换为普通的培养液A继续培养24小时,以5×104个细胞/孔接种96孔板。
4.根据权利要求3所述的一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,所述培养液A由45mlDMEM高糖培养基、5%FBS、1%青链霉素构成。
5.根据权利要求4所述的一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,所述培养液B由培养液A、5μg/ml polybrene构成。
6. 根据权利要求5所述的一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,所述培养液C由43.5ml KO-DMEM培养基、5%FBS、1%鸡血清、1%青链霉素、0.4%非必须氨基酸、0.2μlβ-巯基乙醇、100μl hSCF (5ng/ml)、100μlbfgf(10ng/ml)、50μl LIF(10ng/ml)构成。
7. 根据权利要求6所述的一种新型鸡CEF重编程为PGC的诱导体系的建立方法,其特征是,所述培养液D由培养液C、500ng/mlBMP4、500 ng/ml BMP8b、50 ng/ml EGF构成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910514421.9A CN110205299A (zh) | 2019-06-14 | 2019-06-14 | 一种新型鸡cef重编程为pgc的诱导体系的建立方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910514421.9A CN110205299A (zh) | 2019-06-14 | 2019-06-14 | 一种新型鸡cef重编程为pgc的诱导体系的建立方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110205299A true CN110205299A (zh) | 2019-09-06 |
Family
ID=67792644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910514421.9A Pending CN110205299A (zh) | 2019-06-14 | 2019-06-14 | 一种新型鸡cef重编程为pgc的诱导体系的建立方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110205299A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111534481A (zh) * | 2020-05-18 | 2020-08-14 | 扬州大学 | 一种提高鸡胚成纤维细胞体外诱导重编程为iPS细胞效率的方法 |
CN111690594A (zh) * | 2020-07-16 | 2020-09-22 | 扬州大学 | 一种鸡两性cef的体外分离和培养方法 |
CN112553258A (zh) * | 2021-01-08 | 2021-03-26 | 扬州大学 | 一种鸡成纤维细胞转分化为原始生殖细胞介导生产转基因鸡的方法 |
CN113355359A (zh) * | 2021-06-11 | 2021-09-07 | 扬州大学 | 一种高效生产类克隆鸡的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160333319A1 (en) * | 2011-06-10 | 2016-11-17 | University Of Georgia Research Foundation, Inc. | Avian Induced Pluripotent Stem Cells and Their Use |
-
2019
- 2019-06-14 CN CN201910514421.9A patent/CN110205299A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160333319A1 (en) * | 2011-06-10 | 2016-11-17 | University Of Georgia Research Foundation, Inc. | Avian Induced Pluripotent Stem Cells and Their Use |
Non-Patent Citations (1)
Title |
---|
H. WANG等: "Induction of Germ Cell-like Cells from Porcine Induced Pluripotent Stem Cells", 《SCI REP》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111534481A (zh) * | 2020-05-18 | 2020-08-14 | 扬州大学 | 一种提高鸡胚成纤维细胞体外诱导重编程为iPS细胞效率的方法 |
CN111690594A (zh) * | 2020-07-16 | 2020-09-22 | 扬州大学 | 一种鸡两性cef的体外分离和培养方法 |
CN112553258A (zh) * | 2021-01-08 | 2021-03-26 | 扬州大学 | 一种鸡成纤维细胞转分化为原始生殖细胞介导生产转基因鸡的方法 |
CN113355359A (zh) * | 2021-06-11 | 2021-09-07 | 扬州大学 | 一种高效生产类克隆鸡的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110205299A (zh) | 一种新型鸡cef重编程为pgc的诱导体系的建立方法 | |
US20200239842A1 (en) | Preparation and Expansion Methods for Human Pluripotent Stem Cell-Derived Human Retinal Pigment Epithelial Cells | |
JP6824267B2 (ja) | ヒト誘導多能性幹細胞からライディッヒ細胞への分化誘導方法及びその用途 | |
CN106032527B (zh) | 一种耐受低密度的无饲养层人多能干细胞培养基 | |
CN105505860B (zh) | 一种食管上皮干细胞的分离培养方法 | |
CN105518123A (zh) | 制备眼前段组织的方法 | |
CN106520687A (zh) | 一种诱导多能干细胞向间充质干细胞分化的方法 | |
CN105683359A (zh) | 将从间充质干细胞诱导的多能干细胞分化为肝细胞的方法 | |
CN115747140A (zh) | 一种诱导鸡胚胎干细胞分化生成原始生殖细胞的方法 | |
CN1884494B (zh) | 诱导人胚胎干细胞向肝脏细胞分化的方法及其专用培养基 | |
CN100455661C (zh) | 一种禽类精原干细胞的体外培养方法 | |
CN114807034A (zh) | 一种人多能干细胞来源的Müller细胞的制备方法 | |
AU2021101223A4 (en) | METHOD FOR LONG-TERM IN VITRO CULTURE OF CHICKEN PGCs | |
CN107129966B (zh) | 一种含血清的角膜上皮细胞培养液 | |
CN109722411B (zh) | 一种促进胚胎干细胞自我更新状态的小分子的应用方法 | |
CN105358707A (zh) | 筛选多能干细胞生长促进因子的方法 | |
US20190177690A1 (en) | Method and system for culturing corneal stem cell-like cell line by inducing differentiation of induced pluripotent stem cell using protein ligand | |
CN104195102A (zh) | 诱导人胚胎干细胞向神经外胚层分化的方法 | |
CN106701663B (zh) | 一种人母乳干细胞的制备方法及其应用 | |
CN102994447B (zh) | 一种培养扩增人类毛囊干细胞及重编程为诱导多能干细胞的方法 | |
CN107236703B (zh) | 一种饲养层细胞、培养方法及应用 | |
CN113046311B (zh) | 一种诱导多能干细胞定向分化为淋巴组织诱导细胞的方法 | |
CN106479956B (zh) | 一种提高体细胞重编程效率的培养基及方法 | |
CN113355359A (zh) | 一种高效生产类克隆鸡的方法 | |
CN101445791A (zh) | 一种筛选多潜能细胞的方法及其专用培养基 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190906 |
|
RJ01 | Rejection of invention patent application after publication |